# Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary

> **NCT02429570** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 30 (actual)

## Conditions studied

- Recurrent Brain Metastases
- Progressive Brain Metastases

## Interventions

- **DRUG:** Meclofenamate

## Key facts

- **NCT ID:** NCT02429570
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-04-22
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02429570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02429570, "Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02429570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*